Year 1: Clinical | Year 2: Differentiation | Year 3 and Beyond | Current Fellows
Year 1: Clinical
The first year of ID fellowship in the combined MGH-BWH program offers an intensive experience in diverse inpatient and outpatient clinical care. First year fellows rotate through inpatient rotations at both the MGH and BWH, including rotations in general ID, transplant ID (both solid organ and bone marrow), and on teams staffed by experts in HIV care. Fellows also work at the Mass Eye and Ear Infirmary and the Dana Farber Cancer Institute. Electives in pediatric ID are available. Fellows have a continuity clinic once a week over two years with the same preceptor experienced in both general ID and HIV. Fellows also have a one month rotation in the first year in outpatient specialty clinics managing HCV infection, mycobacterial infections, STIs, outpatient management of infections in immunocompromised hosts, travel and tropical medicine, perinatal and obstetrical infections, and bone and joint infections, among other areas. Fellows additionally spend time rotating through the microbiology lab during this first year. Dues for the Infectious Diseases Society of America (IDSA) are waived for the first 18 months of ID training, and the combined MGH-BWH program covers the dues for first and second year fellows’ membership in the Massachusetts Infectious Diseases Society, an outstanding opportunity for networking.
Year 2: Differentiation
We are committed to training a diverse set of infectious disease fellows with broad interests. The ACGME requirements for ID Board certification are a minimum of two years of supervised training. In Year 2 of our program, our fellows differentiate in two broad directions, those interested in developing into an independent investigator or those interested in careers as primarily a clinician or clinician-educator (generally two or three total years of training- see below).
Investigative Training/Mentored Research
Beginning in Year 2, fellows in the investigator training path work with a specific mentor, learning the tools of investigation and skills to disseminate the work. We have three institutional training grants (T32) providing support for up to two years of additional training with any of a large number of Harvard investigators in a variety of fields. The majority of fellows in this path go on to compete successfully for NIH career development K awards to support longer term mentored training after the T32 period ends and use these for the transition to faculty positions. Many fellows have elected to attend the IDSA and National Institute of Allergy and Infectious Diseases Research Careers conference.
Potential areas of research training are broad. Mentors in the MGB Infectious Disease fellowship conduct research both domestically and in resource-limited settings around the world.
ID fellows in our program have been mentored by faculty in the ID Divisions at MGH and BWH, as well as at Harvard Medical School, the Harvard-Chan School of Public Health, MIT, the Broad Institute, and the Ragon Institute. Although there are some clinical responsibilities and didactic opportunities in Year 2 in this path, these are limited and are designed not to interfere with a fellow’s productivity in mentored research.
Elective coursework in Year 2 of the investigative training path:
July-August: Summer Program in Clinical Effectiveness at the Harvard-Chan School of Public Health for those pursuing research in epidemiology, outcomes, cost-effectiveness, operations and other areas of clinical research
July: Models of Disease Bootcamp for those doing research in more basic science areas
July: Introduction to Human investigation for those performing clinical and translational research in human subjects
Differentiated Training Tracks
For fellows interested in careers as clinicians or clinician-educators, the second year consists of additional intensive training in the ambulatory setting, additional inpatient consultation time, responsibility for setting up and running conferences, and a scholarly project. Well-established and specific clinical training programs exist in:
Medical Microbiology
Infection Prevention, Healthcare Epidemiology, and Antimicrobial Stewardship
Transplant Infectious Disease and Compromised Host Training Program
The year is further enriched with active outpatient programs and mentorship in mycobacterial disease, travel and tropical medicine, STIs, HCV, bone and joint infections, and neuro-ID. At the end of year two of fellowship for those choosing this pathway, many fellows seek clinical positions at academic medical centers; some, however, will elect to extend their fellowship with further years of mentored research.
For more information on Differentiated Training Tracks in Year 2 and beyond, click here.
Year 3 and Beyond
ID fellows become board-eligible after completion of Year 2, but many of our fellows continue training beyond that year. This later component of the fellowship is often the most productive time, particularly in the investigative training path. Although there are no required clinical responsibilities for fellows after Year 2, many of our fellows choose to continue with a component of inpatient clinical consultative work and/or maintain their continuity clinic as a junior faculty attending in Years 3 and beyond, in order to maintain their clinical skills and supplement their salary.
Current First Year Fellows
Elikplim Akaho, MD, MS | Alejandro De La Hoz Gómez, MD | Aliza Green, MD |
---|---|---|
MD: Kwame Nkrumah University of Science & Technology School of Medical Sciences R: Cook County Hospital and Health System |
MD: Pontificia Universidad Javeriana Bogotá Facultad de Medicina R: Boston University Medical Center |
MD: Icahn School of Medicine at Mount Sinai R: Brigham and Women’s Hospital |
Philip Nussenzweig, MD, PhD | Heidi Park, MD | Katelyn Pastick, MD |
MD: Weill Cornell Medicine R: University of California Los Angeles |
MD: Tufts University School of Medicine R: Tufts Medical Center |
MD: University of Minnesota Medical School R: Massachusetts General Hospital |
Sara Rendell, MD, PhD | Daniel Resnick, MD, MS | Jonathan Turner, MD, PhD |
MD: Perelman School of Medicine at the University of Pennsylvania R: University of Pennsylvania |
MD: Perelman School of Medicine at the University of Pennsylvania R: Emory University |
MD: Medical University of South Carolina College of Medicine R: Massachusetts General Hospital |
Frances Ue, MD, MPH | ||
MD: Saint Louis University School of Medicine R: Cambridge Health Alliance |
Current Second Year Fellows
Akanksha Arya, MD, MBA | Simran Gupta, MD | Sam Maldonado, MD, PhD |
---|---|---|
MD: Rutgers Robert Wood Johnson Medical School R: Thomas Jefferson University |
MD: University of Connecticut School of Medicine R: Mayo Clinic Arizona |
MD: Rutgers New Jersey Medical School R: University of Virginia |
Fizza Manzoor, MD | Gabriela Milla, MD | Gabriel Motoa Cardona, MD |
MD: University of Toronto Faculty of Medicine R: University of Toronto |
MD: Universidad Nacional Autónoma de Honduras Facultad de Ciencias Médicas R: MetroWest/Tufts University |
MD: Universidad del Valle Escuela de Medicina R: University of Miami |
Carlos Portales, MD | César Rodriguez, MD | Dipesh Solanky, MD |
MD: Universidad Autónoma de San Luis Potosí Facultad de Medicina R: Rochester General Hospital |
MD: University of Massachusetts TH Chan School of Medicine R: Columbia University |
MD: Mayo Clinic Alix School of Medicine R: University of California at San Diego |